tradingkey.logo
tradingkey.logo
Buscar

Know Labs Inc

KNW
Añadir a la lista de seguimiento
2.140USD
0.0000.00%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
16.05MCap. mercado
PérdidaP/E TTM

Más Datos de Know Labs Inc Compañía

Know Labs, Inc. is a developer of non-invasive diagnostics technology. The Company’s platform technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. The technology is designed to be able to integrate into a variety of wearable, mobile or bench-top form factors. Its patent-pending technology makes it possible to identify and monitor analytes that could only previously be performed by invasive and/or expensive and time-consuming lab-based tests. The Company’s expected application of the technology is focused on a product marketed as a non-invasive glucose monitor. The device is designed to provide the user with accessible and affordable real-time information on blood glucose levels. Its sensor technology embodies two key components: hardware and software. The hardware component includes a sensor which both sends and receives a radio frequency signal. The Company’s wholly owned subsidiary is Particle, Inc.

Información de Know Labs Inc

Símbolo de cotizaciónKNW
Nombre de la empresaUSBC Inc
Fecha de salida a bolsaApr 12, 2006
Director ejecutivoMr. Robert Gregory Kidd
Número de empleados12
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 12
Dirección619 Western Ave
CiudadSEATTLE
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal98104
Teléfono12069031351
Sitio Webhttps://www.knowlabs.co/
Símbolo de cotizaciónKNW
Fecha de salida a bolsaApr 12, 2006
Director ejecutivoMr. Robert Gregory Kidd

Ejecutivos de Know Labs Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ronald Peter Erickson, J.D.
Mr. Ronald Peter Erickson, J.D.
Senior Vice President, President - Science Division
Senior Vice President, President - Science Division
2.47M
+0.07%
Adm. William Arthur (Bill) Owens
Adm. William Arthur (Bill) Owens
Independent Director
Independent Director
48.69K
--
Mr. Ichiro John Paul Takesako
Mr. Ichiro John Paul Takesako
Independent Director
Independent Director
28.88K
--
Mr. Robert Gregory (Greg) Kidd
Mr. Robert Gregory (Greg) Kidd
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Kitty B. Payne, CPA
Ms. Kitty B. Payne, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Linda Jenkinson
Ms. Linda Jenkinson
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Larry K. Ellingson
Mr. Larry K. Ellingson
Independent Director
Independent Director
--
--
Mr. Jon Pepper
Mr. Jon Pepper
Independent Director
Independent Director
--
--
Mr. Kirk Chapman
Mr. Kirk Chapman
Chief Operating Officer
Chief Operating Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ronald Peter Erickson, J.D.
Mr. Ronald Peter Erickson, J.D.
Senior Vice President, President - Science Division
Senior Vice President, President - Science Division
2.47M
+0.07%
Adm. William Arthur (Bill) Owens
Adm. William Arthur (Bill) Owens
Independent Director
Independent Director
48.69K
--
Mr. Ichiro John Paul Takesako
Mr. Ichiro John Paul Takesako
Independent Director
Independent Director
28.88K
--
Mr. Robert Gregory (Greg) Kidd
Mr. Robert Gregory (Greg) Kidd
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Kitty B. Payne, CPA
Ms. Kitty B. Payne, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Linda Jenkinson
Ms. Linda Jenkinson
Vice Chairman of the Board
Vice Chairman of the Board
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Know Labs Inc?

Los cinco principales accionistas de Know Labs Inc son: Mr. Ronald Peter Erickson, J.D.

¿Cuántas instituciones poseen acciones de Know Labs Inc (KNW)?

A fecha de 2026Q1, 67 instituciones poseen acciones de Know Labs Inc, con un valor de mercado combinado de aproximadamente 3.90M, lo que representa el 1.01% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 1085949.00.